PARSIPPANY, N.J. - Zoetis Inc . (NYSE:ZTS), a global leader in animal health, has announced a quarterly dividend of $0.50 per share for the second quarter of 2025. The declared dividend is payable on ...

The pet industry is expected to witness significant growth, driven by the surging demand for pet products and healthcare ...

Zoetis (ZTS) announced that it has updated the U.S. label for Librela, following its submission of a supplement to the FDA. This supplement ...

Indeed, not soon after the approval of Zoetis’ interleukin 31 ... of vaccine development to create vaccines for companion animals, such as dogs and cats—a market that was estimated to be ...

Zoetis (NYSE:ZTS – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, ...

Vaccine will help poultry producers and veterinarians fight rapidly emerging avian metapneumovirus in the United States ...

Growth in the sales of the company’s vaccine portfolio ... like Librela for dogs and Solensia for cats, dermatology products, such as Apoquel and Cytopoint, as well as Zoetis’ new parasiticide ...